StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) income statement

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.60+0.14 (+1.34%)

Close on Nov 17, 2026Market cap $891.37MP/E 13.8Yield –

Bioventus Inc. income statement

Ratios

Latest available, balances at Jun 27, 2026

Profitability, TTM

Gross margin
68.7%
Operating margin
10.0%
Net margin
9.4%
Return on equity, FY2025
13.7%

Financial strength

Current ratio
1.69
Debt to equity
1.09
Debt to assets
36.9%
Cash to current liabilities
19.3%

Valuation

P/E ratio
13.8
Price to sales
1.53
Price to book
3.90
Dividend yield
–

See a number that looks wrong?